Our data supported that IL-17 signaling can increase the expression of proinflammatory cytokines and decrease the expression of anti-inflammatory cytokines in P. aeruginosa-infected COPD mouse models, which suggested that IL-17 signaling blockade is a potential approach to resolute infection-associated inflammation in AECOPD. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.